Beta-lactam antibiotics as reserve medications for the treatment of drug-resistant tuberculosis

Beta-lactam antibiotics as reserve medications for the treatment of drug-resistant tuberculosis

The review article presents an analysis of literature data on the necessity to expand the range of medications possessing anti-tuberculosis activity for the treatment of the most severe forms of drug-resistant tuberculosis through the use of beta-lactam antibiotics in chemotherapy regimens. The mech...

Full description

Saved in:

Bibliographic Details
Main Authors:	G. N. Mozhokina, A. G. Samoilova, I. A. Vasilyeva
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2021-08-01
Series:	Антибиотики и Химиотерапия
Subjects:	drug-resistant tuberculosis beta lactams carbapenems anti-tuberculosis activity
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/823
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinic study of the treatment of hemodialysis combined with hemoperfusion in hemodialysis patients with beta-lactam antibiotics encephalopathy
by: LI Xin-lun, et al.
Published: (2015-01-01)

Beta-Lactam Antibiotic Concentrations and the Acquisition of Multi-Drug Resistant Bacteria in Critically Ill Patients
by: Anita Farinella, et al.
Published: (2025-05-01)

Cefotaxime/Sulbactam: an Important Addition to the Arsenal of Inhibitor-Protected Beta-Lactam Antibiotics
by: S. V. Yakovlev, et al.
Published: (2020-05-01)

Development of a UHPLC-UV/Vis Method for Simultaneously Determining Six Beta-Lactam Antibiotics in Plasma: A Tool for the Clinical Implementation of Therapeutic Monitoring of Beta-Lactams
by: Iria Varela-Rey, et al.
Published: (2025-06-01)

Impact of Timing of Beta-Lactam Therapeutic Drug Monitoring and Therapy Adjustment in Critically Ill Patients
by: Mohammad H. Alshaer, et al.
Published: (2025-05-01)

SNP Polymorphism in Genomes of CC320 Isolates of Streptococcus pneumoniae Resistant to Beta-Lactams
by: I. A. Tzvetkova, et al.
Published: (2020-05-01)

Rapid Analysis of the Sensitivity of Bacteria to Beta-Lactam Antibiotics by Using a Resonator with a Lateral Electric Field
by: O. I. Guliy, et al.
Published: (2020-05-01)

Exploring β-lactam interactions with DacB1: unraveling optimal therapies for combating drug-resistant Mycobacterium tuberculosis
by: Mary Nantongo, et al.
Published: (2025-08-01)

Possibilities of Using Nootropic Drugs to Reduce Neurotoxic Reactions Caused by Anti-tuberculosis Drugs in Experimental Conditions
by: G. N. Mozhokina, et al.
Published: (2024-07-01)

Beta-lactam antibiotics use in intensive care units - the pathophysiological, pharmacokinetic, pharmacodynamic and pharmacoeconomic approach
by: Perić Aneta, et al.
Published: (2015-01-01)

Cefepime/Sulbactam — A New Innovative Antibiotic for In-Hospital Treatment of Severe Infections and the Implementation of Carbapenem-Replacement Strategy to Contain Antibiotic Resistance
by: S. V. Yakovlev, et al.
Published: (2021-06-01)

Effect of reserved line’s anti-tuberculosis medicines to antiinflammatory cytokine production for patients with pulmonary tuberculosis
by: T. Ye. Kononova, et al.
Published: (2010-10-01)

High Prevalence of blaOXA-2 and blaOXA-10 Genes in the β-Lactam-Resistant Clinical Isolates of Pseudomonas aeruginosa
by: Fatemeh Bazari Jamkhaneh, et al.
Published: (2022-05-01)

Experience of using bedaquiline in the treatment of pulmonary tuberculosis patients with multiple drug resistance
by: T. I. Morozova, et al.
Published: (2016-02-01)

The Effectiveness of a Succinate-Containing Medication in Accompanying Therapy of Comorbid Tuberculosis in a Penitentiary Institution
by: V. M. Kolomiets, et al.
Published: (2020-12-01)

The eﬀectiveness of psychological support with the use of hepato-immunoprotectors as predictors in drug therapy of tuberculosis
by: V. M. Kolomiets, et al.
Published: (2021-08-01)

Toxicity of treatment regimens for drugresistant tuberculosis.
by: G. N. Mozhokina, et al.
Published: (2022-03-01)

Quantitative release assessment for beta-lactamase-producing Escherichia coli of dairy origin into vegetables
by: Kohei Makita, et al.
Published: (2024-09-01)

Beta‐Lactam Antibiotics Promote Extracellular Vesicle Production of Staphylococcus aureus Through ROS‐Mediated Lipid Metabolic Reprogramming
by: Xiaonan Huang, et al.
Published: (2025-05-01)

Factors associated with post-treatment resorption of lung cavities in individuals with first episodes of drug-sensitive cavitary pulmonary tuberculosis in China
by: Xue Li, et al.
Published: (2025-07-01)

TUBERCULOSIS IN THE PENITENTIARY SYSTEM IN THE COUNTRIES OF EUROPE AND THE RUSSIAN FEDERATION
by: I. A. Vasilyeva, et al.
Published: (2018-06-01)

Unusual Co-existence of Drug-Susceptible Lung Tuberculosis and Drug-Resistant Pleural Tuberculosis: A Rare Case Presentation of Dual Infection
by: Herikurniawan Herikurniawan, et al.
Published: (2025-07-01)

β-Lactam Antibiotics—Drug-Drug Interaction Mediated by Organic Anion Transporters OAT1 and OAT3
by: I. A. Mazerkina, et al.
Published: (2020-09-01)

Unfavorable side effects to first line anti-tuberculosis drugs
by: N. A. Stepanova, et al.
Published: (2016-05-01)

DRUG RESISTANCE OF STRAINS OF M. TUBERCULOSIS, ISOLATED FROM PULMONARY TUBERCULOSIS PATIENTS IN VLADIMIR REGION IN 2013
by: E. S. Dyuzhik, et al.
Published: (2015-10-01)

Combatting <i>Pseudomonas aeruginosa</i> with β-Lactam Antibiotics: A Revived Weapon?
by: Dylan W. Zhao, et al.
Published: (2025-05-01)

Puzzling Clinical Appearance of a Pancreatic Tuberculosis Case
by: Anak Agung Fendy Tri Wicaksana, et al.
Published: (2023-11-01)

Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis
by: N. Yu. Nikolenko, et al.
Published: (2021-07-01)

Use of Dispersible Fixed-Dose Combinations in Chemotherapy of Drug Susceptible Tuberculosis: Results of the Observational Study
by: E. S. Nikitina, et al.
Published: (2024-10-01)

SOCIO-EPIDEMIOLOGICAL ASPECTS OF PREVENTION OF TUBERCULOSIS AMONG WORKERS OF MEDICAL ORGANIZATIONS
by: G. M. Abdylaeva
Published: (2018-05-01)

Experience of Fixed-Dose Combinations of Anti-Tuberculosis Drugs for Preventive Treatment in Children
by: O. D. Baronova, et al.
Published: (2023-12-01)

Study on the chemical stability of β-lactam antibiotics in concomitant simple suspensions with magnesium oxide
by: Ginjiro Kato, et al.
Published: (2024-11-01)

Mycobacteria Presence and Anti-Tuberculosis Drug Resistance Profile in Düzce Region: 18 Years of Experience
by: Emel Akbaş, et al.
Published: (2025-04-01)

Characterization of drug susceptibility of Mycobacterium tuberculosis isolated from new cases of tuberculosis concurrent with HIV infection
by: G. V. Panov, et al.
Published: (2015-02-01)

EFFICIENCY AND SAFETY OF CHEMOTHERAPY REGIMEN WITH SQ109 IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS
by: S. E. Borisov, et al.
Published: (2018-04-01)

Enhanced removal of β-lactam antibiotics from synthetic wastewater via bioaugmentation of MBBR by MBL-positive Pseudomonas aeruginosa
by: Mohammad Javad Shokoohizadeh, et al.
Published: (2025-07-01)

In vitro photodynamic inactivation of Mycobacterium tuberculosis by methylene blue
by: D. A. Bredikhin, et al.
Published: (2019-08-01)

A Unique Case of Cure of the Patient with Disseminated Bilateral Fibrous Cavernous Pulmonary Tuberculosis with Extensive Drug Resistance after 18 Years of Treatment Failures
by: O. G. Komissarova, et al.
Published: (2024-12-01)

Transforming intestinal tuberculosis management: advances in diagnostics, therapeutics, and prevention
by: Tamer A. Addissouky
Published: (2025-07-01)

Evaluation of the Effect of Comorbidity on the Efficacy and Safety of β-Lactam Antibiotics in Patients with Community-Acquired Pneumonia
by: O. V. Muslimova, et al.
Published: (2022-07-01)